351 related articles for article (PubMed ID: 25348612)
1. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z
J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612
[TBL] [Abstract][Full Text] [Related]
2. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.
Liang C; Li F; Wang L; Zhang ZK; Wang C; He B; Li J; Chen Z; Shaikh AB; Liu J; Wu X; Peng S; Dang L; Guo B; He X; Au DWT; Lu C; Zhu H; Zhang BT; Lu A; Zhang G
Biomaterials; 2017 Dec; 147():68-85. PubMed ID: 28938163
[TBL] [Abstract][Full Text] [Related]
4. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
5. Transcriptional activation of CBFβ by CDK11
Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
Cell Commun Signal; 2019 Oct; 17(1):125. PubMed ID: 31610798
[TBL] [Abstract][Full Text] [Related]
6. Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation.
Duan Z; Zhang J; Choy E; Harmon D; Liu X; Nielsen P; Mankin H; Gray NS; Hornicek FJ
Clin Cancer Res; 2012 Sep; 18(17):4580-8. PubMed ID: 22791884
[TBL] [Abstract][Full Text] [Related]
7. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.
Liao Y; Chen L; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Oncotarget; 2017 May; 8(18):30276-30287. PubMed ID: 28415820
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.
Liao Y; Sassi S; Halvorsen S; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Sci Rep; 2017 Mar; 7():43941. PubMed ID: 28262798
[TBL] [Abstract][Full Text] [Related]
9. Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein.
Zhou Y; Li Y; Zhang Y; Yi Z; Jiang M
Mol Cell Biochem; 2022 Sep; 477(9):2183-2191. PubMed ID: 35445373
[TBL] [Abstract][Full Text] [Related]
10. Applications of CRISPR/Cas9 in the research of malignant musculoskeletal tumors.
Liu W; Wang S; Lin B; Zhang W; Ji G
BMC Musculoskelet Disord; 2021 Feb; 22(1):149. PubMed ID: 33546657
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.
Liu T; Yan Z; Liu Y; Choy E; Hornicek FJ; Mankin H; Duan Z
Cell Physiol Biochem; 2018; 46(3):1218-1230. PubMed ID: 29672299
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.
Zhou Y; Shen JK; Hornicek FJ; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(26):40846-40859. PubMed ID: 27049727
[TBL] [Abstract][Full Text] [Related]
13. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
14. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma.
Mizoshiri N; Shirai T; Terauchi R; Tsuchida S; Mori Y; Hayashi D; Kishida T; Arai Y; Mazda O; Nakanishi T; Kubo T
Cell Oncol (Dordr); 2019 Dec; 42(6):861-871. PubMed ID: 31494861
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
17. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
18. Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.
Tang F; Min L; Seebacher NA; Li X; Zhou Y; Hornicek FJ; Wei Y; Tu C; Duan Z
J Orthop Res; 2019 Mar; 37(3):789-798. PubMed ID: 30667081
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.
Jafari N; Kim H; Park R; Li L; Jang M; Morris AJ; Park J; Huang C
PLoS One; 2017; 12(1):e0170327. PubMed ID: 28099519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]